The author of this article was at the Palace of the Presidency for the signing ceremony of Bill No. 5,972/2023, which provides for the expansion of the availability of thrombolytic medications in the emergency and urgency network of the Unified Health System (SUS). The ceremony was brief, as is common at this type of event.
The Bill deals with the provision of thrombolytic medications, used to dissolve clots, in emergency situations. The text highlights that these minutes of care can represent the difference between recovery and disability, or between life and death for patients.
The new rule will aim to bring thrombolysis to the Emergency Care Units (UPAs) and the Mobile Emergency Care Service (Samu), expanding the population's access to this treatment.
However, the success of the measure will depend on the adequate implementation of protocols, the performance of rapid diagnostics, and the guarantee of transport of patients to health units.




